<VariationArchive VariationID="56182" VariationName="NM_000310.4(PPT1):c.169dup (p.Met57fs)" VariationType="Duplication" Accession="VCV000056182" Version="41" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="11" DateLastUpdated="2024-07-23" DateCreated="2013-07-24" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="70821" VariationID="56182">
      <GeneList>
        <Gene Symbol="PPT1" FullName="palmitoyl-protein thioesterase 1" GeneID="5538" HGNC_ID="HGNC:9325" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="40071461" stop="40097252" display_start="40071461" display_stop="40097252" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="40538381" stop="40563141" display_start="40538381" display_stop="40563141" Strand="-" />
          </Location>
          <OMIM>600722</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000310.4(PPT1):c.169dup (p.Met57fs)</Name>
      <CanonicalSPDI>NC_000001.11:40092462:TTTTTTT:TTTTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="40092462" stop="40092463" display_start="40092462" display_stop="40092463" variantLength="1" positionVCF="40092462" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="40558134" stop="40558135" display_start="40558134" display_stop="40558135" variantLength="1" positionVCF="40558134" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>M57fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.40558141dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.40558141dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.40092469dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.40092469dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009192.1" sequenceAccession="NG_009192" sequenceVersion="1" change="g.10008dup">
            <Expression>NG_009192.1:g.10008dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000310.4" sequenceAccession="NM_000310" sequenceVersion="4" change="c.169dup" MANESelect="true">
            <Expression>NM_000310.4:c.169dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000301.1" sequenceAccession="NP_000301" sequenceVersion="1" change="p.Met57fs">
            <Expression>NP_000301.1:p.Met57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363695.2" sequenceAccession="NM_001363695" sequenceVersion="2" change="c.169dup">
            <Expression>NM_001363695.2:c.169dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350624.1" sequenceAccession="NP_001350624" sequenceVersion="1" change="p.Met57fs">
            <Expression>NP_001350624.1:p.Met57fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142604.2" sequenceAccession="NM_001142604" sequenceVersion="2" change="c.125-2951dup">
            <Expression>NM_001142604.2:c.125-2951dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_690" sequenceAccession="LRG_690">
            <Expression>LRG_690:g.10008dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_690t1" sequenceAccession="LRG_690t1">
            <Expression>LRG_690t1:c.169dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_690p1" sequenceAccession="LRG_690p1" change="p.Met57fs">
            <Expression>LRG_690p1:p.Met57fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000310.3" sequenceAccession="NM_000310" sequenceVersion="3" change="c.169dupA">
            <Expression>NM_000310.3:c.169dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA263481" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600722.0007" DB="OMIM" />
        <XRef Type="rs" ID="386833634" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000310.4(PPT1):c.169dup (p.Met57fs) AND Neuronal ceroid lipofuscinosis 1" Accession="RCV000049593" Version="20">
        <ClassifiedConditionList TraitSetID="2449">
          <ClassifiedCondition DB="MedGen" ID="C1850451">Neuronal ceroid lipofuscinosis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-21" SubmissionCount="7">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000310.4(PPT1):c.169dup (p.Met57fs) AND Neuronal ceroid lipofuscinosis" Accession="RCV000584447" Version="3">
        <ClassifiedConditionList TraitSetID="8888">
          <ClassifiedCondition DB="MedGen" ID="C0027877">Neuronal ceroid lipofuscinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-12-21" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000310.4(PPT1):c.169dup (p.Met57fs) AND not provided" Accession="RCV001009045" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2021-06-24" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-21" NumberOfSubmissions="11" NumberOfSubmitters="11" DateCreated="2013-07-24" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10649502</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10679943</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21990111</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24997880</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26707855</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28878621</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9571187</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-05">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-11-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1409" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis</ElementValue>
                <XRef ID="Neuronal+Ceroid+Lipofuscinosis/5192" DB="Genetic Alliance" />
                <XRef ID="MONDO:0016295" DB="MONDO" />
                <XRef ID="42012007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceroid storage disease</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10739" />
                <XRef ID="10739" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509415" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520997" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509800" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520995" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520996" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500216" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509416" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561937" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520979" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review">
                <ID Source="PubMed">19084560</ID>
              </Citation>
              <XRef ID="216" DB="Orphanet" />
              <XRef ID="79263" DB="Orphanet" />
              <XRef ID="C0027877" DB="MedGen" />
              <XRef ID="MONDO:0016295" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256730" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2449" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="767" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PPT1-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLN1 variable age at onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 1</ElementValue>
                <XRef ID="MONDO:0009744" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Infantile CLN (type of CLN1)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Classic late infantile CLN (type of CLN1)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile CLN (type of CLN1)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult CLN (type of CLN1)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEROID LIPOFUSCINOSIS, NEURONAL, 1, VARIABLE AGE AT ONSET</ElementValue>
                <XRef Type="MIM" ID="256730" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLN1</ElementValue>
                <XRef Type="MIM" ID="256730" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1219" />
                <XRef ID="1219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="228329" DB="Orphanet" />
              <XRef ID="C1850451" DB="MedGen" />
              <XRef ID="MONDO:0009744" DB="MONDO" />
              <XRef Type="MIM" ID="256730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29674" SubmissionDate="2012-07-03" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600722.0007_CEROID LIPOFUSCINOSIS, NEURONAL, 1" title="PPT1, 1-BP INS, 169A_CEROID LIPOFUSCINOSIS, NEURONAL, 1" />
        <ClinVarAccession Accession="SCV000029674" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-04-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 4-year-old boy with infantile-onset CLN1 (256730), Santorelli et al. (1998) identified a single adenine insertion at nucleotide position 169 (160insA) in the PPT gene. The mutation was homozygous in the proband, heterozygous in his healthy parents, and not found in control alleles. The mutation led to an early stop codon, resulting in an abnormal and truncated PPT protein. The 4-year-old boy developed normally until the age of 12 months. He could sit and crawl; however, he never achieved independent walking. Psychomotor regression occurred over the subsequent 2 months. At age 14 months, he had lost most of his motor abilities and showed a progressive worsening of his clinical status. At approximately 18 months of age, he was hypotonic and also presented severe speech impairment, visual loss, and myoclonic seizures. Electroretinogram and visual evoked potentials were altered. MRI showed severe cerebral cortical atrophy with relative sparing of the cerebellum. Ultrastructural studies showed recurrent granular osmiophilic deposits in both endothelial cells and fibroblasts on skin biopsy.</Attribute>
              <Citation>
                <ID Source="PubMed">9571187</ID>
              </Citation>
              <XRef DB="OMIM" ID="256730" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <Name>PPT1, 1-BP INS, 169A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 169A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600722.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEROID LIPOFUSCINOSIS, NEURONAL, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="131389" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS50" />
        <ClinVarAccession Accession="SCV000082000" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">21990111</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Ceroid lipofuscinosis neuronal 1</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="256730" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1349623" SubmissionDate="2018-01-31" DateLastUpdated="2018-02-19" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="NM_000310.3:c.169dupA|MedGen:C0027877" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000692329" DateUpdated="2018-02-19" DateCreated="2018-02-19" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-09-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027877" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3203857</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="539785" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="204401|MedGen:C1850451" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000284561" DateUpdated="2024-02-20" DateCreated="2016-07-01" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10679943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21990111</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9571187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10679943</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21990111</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Met57Asnfs*45) in the PPT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PPT1 are known to be pathogenic (PMID: 10679943, 21990111). This variant is present in population databases (rs386833634, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with infantile neuronal ceroid lipofuscinosis (PMID: 9571187, 10679943, 21990111). This variant is also known as 169 (A169i) and as c.162-163insA. ClinVar contains an entry for this variant (Variation ID: 56182). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.40558134_40558135insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1850451" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7850453" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000310.4:c.169dup|OMIM:256730" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004204147" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.4:c.169dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2468299" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-09">
        <ClinVarSubmissionID localKey="101338|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001246700" DateUpdated="2024-07-15" DateCreated="2020-05-09" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="AT" referenceAllele="A" start="40558134" stop="40558134" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7331152" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_000310_3_PPT1_c_169dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003921784" DateUpdated="2024-07-23" DateCreated="2023-05-06" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with neuronal ceroid lipofuscinosis 1 (MIM#256730). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) &lt;0.01 for a recessive condition (9 heterozygotes, 0 homozygotes). (SP) 0701 - Other protein truncating variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic, and have been observed in individuals with neuronal ceroid lipofuscinosis (ClinVar, Decipher). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported multiple times as pathogenic and likely pathogenic in individuals with neuronal ceroid lipofuscinosis (ClinVar). (SP) 1201 - Heterozygous variant detected likely in trans with a second pathogenic heterozygous variant (p.(Arg151*)) in a recessive disease. (SP) 1205 - This variant has been shown to be maternally inherited (by duo analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2594</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13026601</SubmissionName>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2869239" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000310.3:c.169dupA|Neuronal ceroid lipofuscinosis 1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001453964" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2669437" SubmissionDate="2020-12-31" DateLastUpdated="2021-01-09" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="NM_000310.3:c.169dupA|MedGen:C0027877" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001361118" DateUpdated="2021-01-09" DateCreated="2020-06-22" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10649502</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24997880</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28878621</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9571187</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26707855</ID>
          </Citation>
          <Comment>Variant summary: PPT1 c.169dupA (p.Met57AsnfsX45) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 3.2e-05 in 251438 control chromosomes (gnomAD). c.169dupA has been reported in the literature in individuals affected with Neuronal Ceroid-Lipofuscinosis (Batten Disease) (Santorelli_1998, Waliany_2000, Levin_2014). These data indicate that the variant is likely to be associated with disease. Two publications report experimental evidence demonstrating an effect of the variant on the expression of other genes via whole transcriptome profiling (Tikka_2016, Pezzini_2017). Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0027877" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8831147</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2306848" SubmissionDate="2021-09-26" DateLastUpdated="2021-09-26" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:158874" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001168855" DateUpdated="2021-09-26" DateCreated="2020-03-16" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Reported as c.169-170insA by Waliany et al. (2000) using alternate nomenclature; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 10679943, 9571187, 21990111, 28878621, 10649502, 26707855, 27535533)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2420839</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_52_20210926044204</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="397329" SubmissionDate="2015-03-11" DateLastUpdated="2022-12-24" DateCreated="2015-03-29">
        <ClinVarSubmissionID localKey="NM_000310.3(PPT1):c.169dupA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000220573" DateUpdated="2022-12-24" DateCreated="2015-03-29" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-08-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9571187</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PPT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000310.3:c.169dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Ceroid lipofuscinosis neuronal 1</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="256730" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl_2015_03_01</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29674" TraitType="Disease" MappingType="Name" MappingValue="CEROID LIPOFUSCINOSIS, NEURONAL, 1" MappingRef="Preferred">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7850453" TraitType="Disease" MappingType="XRef" MappingValue="256730" MappingRef="OMIM">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2669437" TraitType="Disease" MappingType="Name" MappingValue="Neuronal ceroid lipofuscinosis" MappingRef="Preferred">
        <MedGen CUI="C0027877" Name="Neuronal ceroid lipofuscinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="539785" TraitType="Disease" MappingType="XRef" MappingValue="C1850451" MappingRef="MedGen">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2306848" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2468299" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1349623" TraitType="Disease" MappingType="XRef" MappingValue="C0027877" MappingRef="MedGen">
        <MedGen CUI="C0027877" Name="Neuronal ceroid lipofuscinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="397329" TraitType="Disease" MappingType="Name" MappingValue="Ceroid lipofuscinosis neuronal 1" MappingRef="Preferred">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="131389" TraitType="Disease" MappingType="Name" MappingValue="Ceroid lipofuscinosis neuronal 1" MappingRef="Preferred">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7331152" TraitType="Disease" MappingType="XRef" MappingValue="256730" MappingRef="OMIM">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2869239" TraitType="Disease" MappingType="Name" MappingValue="Neuronal ceroid lipofuscinosis 1" MappingRef="Preferred">
        <MedGen CUI="C1850451" Name="Neuronal ceroid lipofuscinosis 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

